【レポートの概要（一部）】
1. Report Overview
1.1 The Global Pharma Wholesale and Distribution Industry and Market Review
1.2 The Global Pharma Wholesale and Distribution Industry Structure
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Main Questions Answered by This Analytical Report
1.6 Who is This Study For?
1.7 Methods of Research and Analysis
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Introduction to Pharma Wholesale and Distribution
2.1 The Role of Pharmaceutical Wholesalers: The Middlemen of the Pharmaceutical Industry
2.1.1 Full-Line Wholesalers (FLWs)
2.1.2 Short-Line Wholesalers (SLWs)
2.2 The Chain of Distribution: Wholesalers vs. Logistics Service Providers
2.2.1 Secondary Wholesalers
2.2.2 Direct-to-Pharmacy (DTP) Distribution is Becoming More Prevalent
2.2.3 Major Wholesalers: Distribute a Large Amount of Products to Generate High Profit
2.2.4 Distribution from Large to Small Wholesalers: A Lengthy Distribution Chain
2.2.5 Pharmacy Benefit Managers
2.3 Generating Revenue and Profit
2.3.1 Forward Buying to Avoid Price Increases
2.3.2 Fee-for-Service: A Clearer Pricing Structure
2.3.2.1 Inventory Management Agreements
2.3.3 Discounts: Incentives for Prompt Payment or Bulk Purchases
2.3.4 Reimbursement and Wholesalers
2.3.5 Clawback: The Recovery of Reimbursement Costs by Governments
2.3.6 Parallel Trade: Different Attitudes in Europe and the US
3. The World Pharmaceutical Wholesale and Distribution Market, 2014-2024
3.1 The World Pharmaceutical Wholesale and Distribution Market in 2013, Restricted by Government Price Reductions and Generic Substitution
3.2 The Pharmaceutical Wholesale and Distribution: World Market Forecast, 2014-2024
3.3 Branded and Generic Drugs: Revenue vs. Profit, 2014-2024
3.3.1 Branded and Generic Drugs: Revenue Generation, 2013
3.3.2 Branded Drugs, Generic Drugs and Others: Revenue Forecasts, 2014-2024
3.3.3 Branded Drugs: Revenue Forecast, 2014-2024
3.3.4 Generic Drugs: Revenue Forecast, 2014-2024
4. Pharmaceutical Wholesale and Distribution Industry: Leading National Markets, 2014-2024
4.1 Leading National Markets: The US Dominated in 2013
4.2 Leading National Markets: Revenue The Future of the Leading National Markets: Will the US Continue to Dominate the Market?
4.3 The US Pharma Wholesale and Distribution Market
4.3.1 The Budget Control Act and its Effect on the US Wholesale and Distribution Industry
4.3.2 Legislation to Prevent Counterfeit Drugs Can Differ Between States
4.3.3 An Increase in Fee-For-Service Activity
4.3.4 Pharma Wholesale and Distribution Market in the US: Market Forecast, 2014-2024
4.4 The Leading European (EU5) Pharma Wholesale and Distribution Markets
4.4.1 Differences Between the US and Europe
4.4.2 State-Funded Healthcare and Reimbursement
4.4.3 EU5: Market Forecast, 2014-2024
4.4.4 Germany: Pharma Wholesale and Distribution Market, 2013
4.4.4.1 Healthcare Reform
4.4.4.2 Germany: Reform of AMNOG Pharmaceutical Rebate Law
4.4.4.3 Germany Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.4.5 France: Pharma Wholesale and Distribution Market, 2013
4.4.5.1 France: Social Security Finance Bill 2014
4.4.5.2 France: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.4.6 Italy: Pharma Wholesale and Distribution Market, 2013
4.4.6.1 Italy: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.4.7 Spain: Pharma Wholesale and Distribution Market, 2013
4.4.7.1 Spain: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.4.8 UK: Pharma Wholesale and Distribution Market, 2013
4.4.8.1 Price Cuts in the UK
4.4.8.2 UK: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.5 Japan: Pharma Wholesale and Distribution Market, 2013
4.5.1 Drug Pricing and Performing Fees in Japan
4.5.2 Japan: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.6 China: Pharma Wholesale and Distribution Market, 2013
4.6.1 China: Leading Pharma Wholesale and Distribution Companies, 2013
4.6.2 China: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.7 Brazil: Pharma Wholesale and Distribution Market, 2013
4.7.1 Drug Price Controls in Brazil
4.7.2 Brazil: Leading Pharma Wholesale and Distribution Companies, 2013
4.7.3 Brazil: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.8 India: Pharma Wholesale and Distribution Market, 2013
4.8.1 India: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.9 Russia: Pharma Wholesale and Distribution Market, 2013
4.9.1 Drug Pricing Controls in Russia
4.9.2 Market Trends in Russia
4.9.3 Russia: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.10 Conclusion
5. Leading Pharma Wholesalers and Distributors in 2014: Current and Future Performance
5.1 The Leading Wholesale and Distribution Companies in 2013
5.2 Revenue vs. Profit
5.3 Leading Pharma Wholesale and Distribution Companies: Grouped Forecasts, 2014-2024
5.4 McKesson: The Oldest and Largest Healthcare Services Company in the US
5.4.1 McKesson: Historical Performance, 2008-2013
5.4.2 Future Strategies: Consummate Acquisitions to Complement Existing Business or Expand Businesses
5.4.3 McKesson: Revenue Forecast, 2014-2024
5.5 Cardinal Health: The World’s Second Largest Pharma Wholesaler
5.5.1 Cardinal Health: Historical Performance, 2008-2013
5.5.2 Will CVS Joint Venture and Acquisitions Stimulate Future Growth?
5.5.3 Cardinal Health: Revenue Forecast, 2014-2024
5.6 AmerisourceBergen: Third Largest Global Pharma Wholesaler and Distributor
5.6.1 AmerisourceBergen: Historical Performance, 2008-2013
5.6.2 Will Contracts with Walgreens and Alliance Boots Drive Future Growth?
5.6.3 AmerisourceBergen: Revenue Forecast 2014-2024
5.7 Alliance Boots: The Largest European Wholesaler
5.7.1 Alliance Boots: Historical Performance, 2008-2013
5.7.2 Future Strategies of Alliance Boots: Merger Plan with Walgreens to Become the Largest Provider of Healthcare Services
5.7.3 Alliance Boots: Revenue Forecast, 2014-2024
5.8 MEDIPAL HOLDINGS CORPORATION: Japan’s Leading Pharmaceutical Wholesaler
5.8.1 MEDIPAL HOLDINGS CORPORATION: Historical Performance, 2008-2013
5.8.2 Future Strategies of MEDIPAL HOLDINGS CORPORATION: Revised Business Portfolio with Diverse Sources of Earnings
5.8.3 MEDIPAL HOLDINGS CORPORATION: Revenue Forecast, 2014-2024
5.9 The PHOENIX Group: Second Biggest Wholesaler in Europe
5.9.1 The PHOENIX Group: Historical Performance, 2008-2013
5.9.2 Future Strategies of the PHOENIX Group: Selective Acquisitions
5.9.3 The PHOENIX Group: Revenue Forecast, 2014-2024
5.10 SINOPHARM: The Leading Pharmaceutical Wholesaler and Distributor in China
5.10.1 SINOPHARM: Historical Performance, 2008-2013
5.10.2 Future Strategies of SINOPHARM: Provide Comprehensive Services and Wider Business Coverage
5.10.3 SINOPHARM: Revenue Forecast, 2014-2024
5.11 Alfresa Holdings: Second Largest Pharmaceutical Wholesaler and Distributor in Japan
5.11.1 Alfresa Holdings: Historical Performance, 2008-2013
5.11.2 Future Strategy of Alfresa Holdings: To Focus on Expanding Business Fields and Increasing Footprint
5.11.3 Alfresa Holdings: Revenue Forecast, 2014-2024
5.12 SUZUKEN CO., LTD: The First Nationwide Wholesaler of Japan
5.12.1 SUZUKEN CO., LTD: Historical Performance, 2008-2013
5.12.2 Future Strategies of SUZUKEN CO., LTD: Five Growth Initiatives and Special Focus on Diabetes Field
5.12.3 SUZUKEN CO., LTD: Revenue Forecast, 2014-2024
5.13 Shanghai Pharmaceuticals Holding: China’s Second Largest Wholesaler
5.13.1 Shanghai Pharmaceuticals Holding: Historical Performance, 2008-2013
5.13.2 Future Strategies of Shanghai Pharma: Expansion of Three Leading Regions in China
5.13.3 Shanghai Pharma: Revenue Forecast, 2014-2024
6. Qualitative Analysis of the Pharma Wholesale and Distribution Market
6.1 Strengths and Weaknesses of the Pharma Wholesale and Distribution Market, 2014
6.1.1 The Insatiable Demand for Drugs: A Recession-Proof Industry?
6.1.2 Wholesalers Do More than Deliver Drugs
6.1.2.1 Pre-Wholesaling: More Prevalent in Europe
6.1.2.2 Through Pre-Financing, Full-Line Wholesalers Finance the Entire Medicines Market
6.1.3 Large Companies Dominate the Market
6.1.4 Despite High Revenues, Profit Margins Are Low
6.1.5 Government-Induced Drug Price Pressures Restrict Profits
6.1.6 The Problem of Counterfeit Drugs
6.2. The Opportunities and Threats of the Pharma Wholesale and Distribution Market, 2014-2024
6.2.1The Demand for Pharmaceuticals is Increasing
6.2.2 The Increasing Use of Specialty Drugs Will Drive Growth
6.2.3 The Increasing Use of Generic Drugs Will Limit Revenue, But Drive Profit Generation
6.2.4 The Promotion of Drug Therapy in the US
6.2.5 Globalisation: The Major National Markets are Dominated by Few Companies
6.2.6 Increased Adoption of the DTP Distribution Model
6.2.6.1 DTP in Europe: The First Place the Scheme Has Taken Hold
6.2.6.2 DTP in the UK Since 1991
6.2.6.3 DTP in Poland: The Second European Country to Adopt the DTP Model
6.2.6.4 Further Expansion of the DTP Model
6.2.7 The Threat of Healthcare Budget Cuts
6.2.7.1 Healthcare Budget Cuts in Germany
6.2.7.2 Healthcare Budget Cuts in France
6.2.7.3 Healthcare Budget Cuts in Italy
6.2.7.4 Healthcare Budget Cuts in Spain
6.2.7.5 Healthcare Budget Cuts in the UK
6.2.8 Do Large Pharmacy Chains Pose a Threat?
6.2.8.1 Case Study: Walmart and the $4.0 Prescription Scheme
6.2.8.2 Vertical Integration of Wholesalers: A Response to the Threat of Pharmacy Chains
6.2.9 Does the Diversion and Re-importation of Medicines Pose a Threat to the Industry?
6.2.10 The Threat of Industry Consolidation
6.3 Social, Technological, Economical and Political Factors Influencing the Market, 2014-2024 (STEP Analysis)
6.3.1 Political Factor: The Impact of Recent Regulatory Changes in the EU
6.3.2 Political Factor: Combating Counterfeit Medicines
6.3.2.1 The US and E-Pedigree: Becoming Law in California
6.3.2.2 European Pedigree Legislation
6.3.2.3 Anti-Counterfeiting Strategies in Other Markets: The Chinese Government is Attempting to Address the Challenge
6.2.3.4 Serialisation for Wholesalers: Opportunity or a Challenge?
7. Research Interviews
7.1 Interview with Mr Chris Frost, Sales Director of AAH Pharmaceuticals Ltd. (Celesio UK), Coventry
7.1.1 Current Status and Evolution of Pharma Wholesale and Distribution Market in the UK
7.1.2 Driving Factors of the Pharma Wholesale and Distribution Market in the UK
7.1.3 Future of the UK Pharma Wholesale and Distribution Market
7.1.4 Celesio UK Accounted for More Than 60% of the Group’s Total Retail Pharmacy Business in 2013
7.1.5 The Outcome of McKesson’s Acquisition of Celesio AG
7.1.6 Prominent Business Segments of Celesio AG in the Future
7.2 Interview with Dr Evelyn Walter, Co-Founder and Director of the Institute for Pharmaeconomic Research (IPF), Vienna
7.2.1 On Direct-to-Pharmacy Distribution
7.2.2 On the Effect of Drug Pricing Pressures on the Supply of Pharmaceuticals
7.2.3 On the Role of Pharmaceutical Wholesalers and Distributors in European Healthcare Systems
7.2.4 On the Impact of Counterfeit Drugs
7.2.5 On the Efficacy of the Pharmaceutical Wholesale and Distribution Industry
8. Conclusions from the Research and Analysis
8.1 The Future of the Pharma Wholesale and Distribution Market
8.2 The Leading National Pharma Wholesale and Distribution Markets
8.3 The Leading Companies in the Pharma Wholesale and Distribution Industry
8.4 Trends in the Pharma Wholesale and Distribution Industry
8.4.1 Generics Will Threaten Revenue
8.4.2 Manufacturers Will Deliver More Drugs Directly
8.4.3 There Will Be Greater Demand for Specialty Medicines
8.4.4 Consolidation Will Drive Growth
8.4.5 Anti-Counterfeiting Demands Will Add to Wholesaler’s Costs
【レポート販売概要】
■ タイトル：世界の医薬品卸売及び流通市場：地域別分析、主要企業分析■ 英文：PHARMA WHOLESALE AND DISTRIBUTION INDUSTRY AND MARKET: WORLD OUTLOOKS AND FORECASTS 2014-2024
■ 発行日：2014年9月
■ 調査会社：visiongain
■ 商品コード：VISG409042
■ 調査対象地域：グローバル
- CMS Energy Corporation：発電所及びSWOT分析2013CMS Energy Corporation - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized …
- 脂肪族炭化水素溶剤・希釈剤の世界市場予測（～2024年）“The aliphatic hydrocarbon solvents & thinners market is projected to grow at a CAGR of 2.7% from 2019 to 2024, in terms of value.” The aliphatic hydrocarbon solvents & thinners market is projected to grow from USD 4.6 billion in 2019 to USD 5.2 billion by 2024, at a CAGR of 2.7% from 2019 to 2024. The increasing demand for aliphatic hydrocarbon solvents & thinners in applications, such as paints …
- 手術用画像装置の世界市場予測（～2022年）：イメージインテンシファイアCアーム、フラットパネルディテクターCアームThe global surgical imaging market is projected to reach USD 1.63 Billion by 2022 from USD 1.25 Billion in 2017, at a CAGR of 5.5% during the forecast period. The growth of this market is majorly driven by factors such as technological advancements in C-arms, increasing demand for minimally invasive procedures, rising geriatric population, and growing chronic disease prevalence. In surgical imagin …
- DS5565（神経因性疼痛）：医薬品市場予測及び分析（～2022）DS5565 (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which is a consequence of trauma, injury, or inflammation. The main difference between neuropathic and nociceptive pain is the absence of a continuous nociceptive input in neuropathic pain. Although the …
- 石油化学製品の世界市場分析：製品別（エチレン、プロピレン、ブタジエン、ベンゼン、キシレン、トルエン、ビニル、スチレン、メタノール）、地域別（北アメリカ、ヨーロッパ、中国、中東、アフリカ、中南米）、セグメント予測、2014-2025The global petrochemicals market is expected to reach USD 958.8 billion by 2025, according to a new report by Grand View Research, Inc. Increasing shale gas exploration coupled with abundant availability of cheap indigenous crude oil in Middle East & Africa is projected to drive demand. Increasing demand for petrochemical products from end-use industries such as automotive, construction, textile, …
- 皮膚がん治療ワクチンの世界市場及びパイプラインインサイトSkin cancer incidences are increasing at alarming rates across the world causing high morbidity and mortality. Research and development in field is expected to change the present scenario by providing better therapeutic options for patients. Skin cancer therapeutics available in market used for first-line treatment have modest efficacy which lays emphasis on the development of better products like …
- IAM（アイデンティティ・アクセス管理）の世界市場：プロビジョニング、ディレクトリサービス、パスワード管理、SSO、監査、コンプライアンス、ガバナンスThe identity and access management market is expected to grow from USD 7.20 Billion in 2015 to USD 12.78 Billion by 2020, at a CAGR of 12.2% during the forecast period. Growing emphasis on compliance management, increasing trend of mobility, and growing demand from BFSI, telecommunication, public, and critical infrastructure sectors across the globe are the top driving factor of IAM market. Audit, …
- コーテッドファブリック（被覆織物）の世界市場2017-2021Coating is an effective tool in the advancement sector of the textile and fabric industry. They contribute to value addition in fabrics, reinforcing them with additional properties that enhance the functional performances of coated fabrics. The applications of coated fabrics are rapidly diversifying and enable us to benefit from products of great use such as waterproof coverings, tents, tarpaulins …
- 有機大豆タンパク質の世界市場予測：大豆タンパク質濃縮物、大豆タンパク質分離物、大豆タンパク質粉The market for organic soy protein is projected to reach USD 500.4 Million by 2021, at a CAGR of about 17.3% from 2016 to 2021. This market is fueled by the growing awareness among consumers toward the health and nutritional benefits of organic foods and the growth of end-use applications of soy protein in the food & beverage industry. Globally, the growth of the functional foods, meat alternative …
- 角膜厚測定の世界市場2019-2023Global Corneal Pachymetry Market: About this market Technavio’s corneal pachymetry market analysis considers sales from both non-handheld and hand-held. Our analysis also considers the sales of corneal pachymetry in Asia, Europe, North America, and ROW. In 2018, the non-handheld segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as …
- ガムロジンの世界市場の規模及び予測：製品別（X、WW、WG、N、M、K）、用途別（接着剤、ゴム軟化剤、紙サイジング、熱可塑性塗料、食品、印刷インキ）、セグメント予測The global gum rosin market is expected to reach USD 2.49 billion by 2024, according to a new report by Grand View Research, Inc. Increasing demand of gum rosin owing to growth of synthetic rubber industry primarily in China is expected to drive the market growth. Increasing demand for high grade gum rosin products including WW and X grade by application industries is expected to benefit the marke …
- 心臓補装具の世界市場：心臓人工弁、冠動脈ステントAbout cardiac prosthetic devices Prosthetic devices are used to replace or support the function of a missing or infirm part in the body. Cardiac prosthetic devices such as stents and prosthetic heart valves are used to maintain the proper functionality of the heart. Stents are used to maintain the blood flow, which reduces due to blockage in the arteries, whereas prosthetic heart valves are being …
- 無菌包装のグローバル市場動向（～2018）The aseptic packaging market is experiencing renewed demand due to the flourishing pharmaceutical sector and the growing global dairy industry. This report estimates the market value and volume of aseptic packaging, by types and applications. In terms of geography, the report is segmented into Asia-Pacific, Europe, North America, and Rest of the World (ROW). The aseptic packaging market is broadly …
- アジア太平洋のクラウドBPO市場2016-2020About Cloud-Based BPO The cloud is set to revolutionize the way BPO service providers extend their offerings and help organizations reap benefits by outsourcing their business processes. For instance, applications can be made available over the network on-demand, with the cloud operating like any other utility service (turning an application on/off on-demand). This eliminates the need to invest in …
- SM Energy Company：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013SM Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary SM Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …
